1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Point-of-care Infectious Disease Diagnostics

1.2 Classification of Point-of-care Infectious Disease Diagnostics by Type

1.2.1 Overview: Global Point-of-care Infectious Disease Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type in 2021

1.2.3 HIV POC

1.2.4 Clostridium Difficile POC

1.2.5 HBV POC

1.2.6 Respiratory Syncytial Virus POC

1.2.7 HPV POC

1.2.8 Influenza/Flu POC

1.2.9 HCV POC

1.2.10 MRSA POC

1.2.11 TB and Drug-Resistant TB POC

1.3 Global Point-of-care Infectious Disease Diagnostics Market by Application

1.3.1 Overview: Global Point-of-care Infectious Disease Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Home

1.3.5 Assisted Living Healthcare Facilities

1.3.6 Laboratories

1.3.7 Others

1.4 Global Point-of-care Infectious Disease Diagnostics Market Size & Forecast

1.5 Global Point-of-care Infectious Disease Diagnostics Market Size and Forecast by Region

1.5.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size by Region, (2017-2022)

1.5.3 North America Point-of-care Infectious Disease Diagnostics Market Size and Prospect (2017-2028)

1.5.4 Europe Point-of-care Infectious Disease Diagnostics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size and Prospect (2017-2028)

1.5.6 South America Point-of-care Infectious Disease Diagnostics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Point-of-care Infectious Disease Diagnostics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Point-of-care Infectious Disease Diagnostics Market Drivers

1.6.2 Point-of-care Infectious Disease Diagnostics Market Restraints

1.6.3 Point-of-care Infectious Disease Diagnostics Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Thermo Fisher Scientific

2.1.1 Thermo Fisher Scientific Details

2.1.2 Thermo Fisher Scientific Major Business

2.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product and Solutions

2.1.4 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott Point-of-care Infectious Disease Diagnostics Product and Solutions

2.2.4 Abbott Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Calypte Biomedical

2.3.1 Calypte Biomedical Details

2.3.2 Calypte Biomedical Major Business

2.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product and Solutions

2.3.4 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Calypte Biomedical Recent Developments and Future Plans

2.4 Chembio Diagnostic Systems

2.4.1 Chembio Diagnostic Systems Details

2.4.2 Chembio Diagnostic Systems Major Business

2.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product and Solutions

2.4.4 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Chembio Diagnostic Systems Recent Developments and Future Plans

2.5 Meridian Bioscience

2.5.1 Meridian Bioscience Details

2.5.2 Meridian Bioscience Major Business

2.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product and Solutions

2.5.4 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Meridian Bioscience Recent Developments and Future Plans

2.6 MedMira

2.6.1 MedMira Details

2.6.2 MedMira Major Business

2.6.3 MedMira Point-of-care Infectious Disease Diagnostics Product and Solutions

2.6.4 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 MedMira Recent Developments and Future Plans

2.7 Trinity Biotech

2.7.1 Trinity Biotech Details

2.7.2 Trinity Biotech Major Business

2.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Product and Solutions

2.7.4 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Trinity Biotech Recent Developments and Future Plans

2.8 Sekisui Diagnostics

2.8.1 Sekisui Diagnostics Details

2.8.2 Sekisui Diagnostics Major Business

2.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product and Solutions

2.8.4 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sekisui Diagnostics Recent Developments and Future Plans

2.9 OraSure Technologies

2.9.1 OraSure Technologies Details

2.9.2 OraSure Technologies Major Business

2.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Product and Solutions

2.9.4 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 OraSure Technologies Recent Developments and Future Plans

2.10 Quidel

2.10.1 Quidel Details

2.10.2 Quidel Major Business

2.10.3 Quidel Point-of-care Infectious Disease Diagnostics Product and Solutions

2.10.4 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Quidel Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Point-of-care Infectious Disease Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Point-of-care Infectious Disease Diagnostics Players Market Share in 2021

3.2.2 Top 10 Point-of-care Infectious Disease Diagnostics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Point-of-care Infectious Disease Diagnostics Players Head Office, Products and Services Provided

3.4 Point-of-care Infectious Disease Diagnostics Mergers & Acquisitions

3.5 Point-of-care Infectious Disease Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Point-of-care Infectious Disease Diagnostics Revenue and Market Share by Type (2017-2022)

4.2 Global Point-of-care Infectious Disease Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2017-2022)

5.2 Global Point-of-care Infectious Disease Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2028)

6.2 North America Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2028)

6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country

6.3.1 North America Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2028)

6.3.2 United States Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

6.3.3 Canada Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

6.3.4 Mexico Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2028)

7.2 Europe Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2028)

7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country

7.3.1 Europe Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2028)

7.3.2 Germany Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

7.3.3 France Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

7.3.5 Russia Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

7.3.6 Italy Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2028)

8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2028)

8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region

8.3.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Region (2017-2028)

8.3.2 China Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8.3.3 Japan Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8.3.4 South Korea Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8.3.5 India Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

8.3.7 Australia Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2028)

9.2 South America Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2028)

9.3 South America Point-of-care Infectious Disease Diagnostics Market Size by Country

9.3.1 South America Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2028)

9.3.2 Brazil Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

9.3.3 Argentina Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2028)

10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2028)

10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country

10.3.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2028)

10.3.2 Turkey Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

10.3.4 UAE Point-of-care Infectious Disease Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Point-of-care Infectious Disease Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Point-of-care Infectious Disease Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Point-of-care Infectious Disease Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Region (2023-2028)

Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific Major Business

Table 8. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 9. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 13. Abbott Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Calypte Biomedical Corporate Information, Head Office, and Major Competitors

Table 15. Calypte Biomedical Major Business

Table 16. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 17. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Chembio Diagnostic Systems Corporate Information, Head Office, and Major Competitors

Table 19. Chembio Diagnostic Systems Major Business

Table 20. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 21. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Meridian Bioscience Corporate Information, Head Office, and Major Competitors

Table 23. Meridian Bioscience Major Business

Table 24. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 25. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. MedMira Corporate Information, Head Office, and Major Competitors

Table 27. MedMira Major Business

Table 28. MedMira Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 29. MedMira Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Trinity Biotech Corporate Information, Head Office, and Major Competitors

Table 31. Trinity Biotech Major Business

Table 32. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 33. Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors

Table 35. Sekisui Diagnostics Major Business

Table 36. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 37. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. OraSure Technologies Corporate Information, Head Office, and Major Competitors

Table 39. OraSure Technologies Major Business

Table 40. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 41. OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Quidel Corporate Information, Head Office, and Major Competitors

Table 43. Quidel Major Business

Table 44. Quidel Point-of-care Infectious Disease Diagnostics Product and Solutions

Table 45. Quidel Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Point-of-care Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Point-of-care Infectious Disease Diagnostics Players Head Office, Products and Services Provided

Table 50. Point-of-care Infectious Disease Diagnostics Mergers & Acquisitions in the Past Five Years

Table 51. Point-of-care Infectious Disease Diagnostics New Entrants and Expansion Plans

Table 52. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) by Type (2017-2022)

Table 53. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Type (2017-2022)

Table 54. Global Point-of-care Infectious Disease Diagnostics Revenue Forecast by Type (2023-2028)

Table 55. Global Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022)

Table 56. Global Point-of-care Infectious Disease Diagnostics Revenue Forecast by Application (2023-2028)

Table 57. North America Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Point-of-care Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Point-of-care Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Point-of-care Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Point-of-care Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Point-of-care Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Point-of-care Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Point-of-care Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Point-of-care Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Point-of-care Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Point-of-care Infectious Disease Diagnostics Picture

Figure 2. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type in 2021

Figure 3. HIV POC

Figure 4. Clostridium Difficile POC

Figure 5. HBV POC

Figure 6. Respiratory Syncytial Virus POC

Figure 7. HPV POC

Figure 8. Influenza/Flu POC

Figure 9. HCV POC

Figure 10. MRSA POC

Figure 11. TB and Drug-Resistant TB POC

Figure 12. Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application in 2021

Figure 13. Hospitals Picture

Figure 14. Clinics Picture

Figure 15. Home Picture

Figure 16. Assisted Living Healthcare Facilities Picture

Figure 17. Laboratories Picture

Figure 18. Others Picture

Figure 19. Global Point-of-care Infectious Disease Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 20. Global Point-of-care Infectious Disease Diagnostics Revenue and Forecast (2017-2028) & (USD Million)

Figure 21. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)

Figure 22. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Region in 2021

Figure 23. North America Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Europe Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 26. South America Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 27. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 28. Point-of-care Infectious Disease Diagnostics Market Drivers

Figure 29. Point-of-care Infectious Disease Diagnostics Market Restraints

Figure 30. Point-of-care Infectious Disease Diagnostics Market Trends

Figure 31. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 32. Abbott Recent Developments and Future Plans

Figure 33. Calypte Biomedical Recent Developments and Future Plans

Figure 34. Chembio Diagnostic Systems Recent Developments and Future Plans

Figure 35. Meridian Bioscience Recent Developments and Future Plans

Figure 36. MedMira Recent Developments and Future Plans

Figure 37. Trinity Biotech Recent Developments and Future Plans

Figure 38. Sekisui Diagnostics Recent Developments and Future Plans

Figure 39. OraSure Technologies Recent Developments and Future Plans

Figure 40. Quidel Recent Developments and Future Plans

Figure 41. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players in 2021

Figure 42. Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Point-of-care Infectious Disease Diagnostics Revenue Market Share in 2021

Figure 44. Global Top 10 Players Point-of-care Infectious Disease Diagnostics Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Type in 2021

Figure 47. Global Point-of-care Infectious Disease Diagnostics Market Share Forecast by Type (2023-2028)

Figure 48. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application in 2021

Figure 49. Global Point-of-care Infectious Disease Diagnostics Market Share Forecast by Application (2023-2028)

Figure 50. North America Point-of-care Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)

Figure 51. North America Point-of-care Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)

Figure 52. North America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)

Figure 53. United States Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Point-of-care Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)

Figure 57. Europe Point-of-care Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)

Figure 58. Europe Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)

Figure 59. Germany Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Point-of-care Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Point-of-care Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)

Figure 67. China Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Point-of-care Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)

Figure 74. South America Point-of-care Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)

Figure 75. South America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Point-of-care Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Point-of-care Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source